Our team contributed to the American Association for Cancer Research’s (AACR) Annual Meeting in Chicago, USA, from April 25th to 30th. Three researchers attended and shared their work: Dr Zeina Nehme and Dr Romain Désert presented a poster “Reversing resistance to checkpoint inhibitors by treatment with Claudin-1 specific antibodies in an orthotopic in vivo model for cholangiocarcinoma”, while Dr Emilie Crouchet presented a poster as well as an oral communication “Targeting Peroxiredoxin 2 prevents hepatocellular carcinoma development in metabolic liver disease”.



As always, we are very proud to see our researchers contribute to great international events – congratulations!
